MOMBA is a selective, orally bioavailable DREADD agonist for engineered hFFA2 receptors. It potently inhibits cAMP production in vitro and, in transgenic mouse models, slows gut transit and stimulates GLP-1 secretion from colonic crypts, making it a valuable research tool for studying metabolic and gastrointestinal physiology.
Molekulargewicht:
166.17
CAS Nummer:
[6880-04-2]
Formel:
C9H10O3
Target-Kategorie:
Others,GPCR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten